Nanosyrinx appoints Edwin Moses as its Chairperson Nanosyrinx appoints Edwin Moses as its Chairperson With more than 30 years of executive-level experience, Edwin will aim to maximise the value of the company's nanosyringe platform Enzene appoints Norm Stoffregen as Site Head of its US biomanufacturing facility Enzene appoints Norm Stoffregen as Site Head of its US biomanufacturing facility The CDMO has appointed Norm to run the USD $50m manufacturing facility in New Jersey Amphista Therapeutics appoints new CEO, Antony Mattessich Amphista Therapeutics appoints new CEO, Antony Mattessich Antony will be responsible for assisting the growth and development of the company and its therapeutic assets Johnson & Johnson's Kristen Mulholland appointed as Chief Human Resources Officer Johnson & Johnson's Kristen Mulholland appointed as Chief Human Resources Officer Kristen will replace Peter Fasolo, who will retire after 16 years of service for the company Jochen Schmidt appointed new Managing Director of Romaco Pharmatechnik GmbH Jochen Schmidt appointed new Managing Director of Romaco Pharmatechnik GmbH Romaco Holding GmbH has just appointed Jochen Schmidt as new Managing Director of Romaco Pharmatechnik GmbH. He will be responsible with immediate effect for the Romaco... Bio X Cell appoints Christopher Conway as CEO Bio X Cell appoints Christopher Conway as CEO Christopher will work with the executive board members to guide the company's global expansion strategy Emirates Biotech bolsters executive board with four new appointments Emirates Biotech bolsters executive board with four new appointments The company has brought in a new CEO, CCO, CTO and a Head of Finance to boost its footprint in the Middle East, Africa and India Corex Logistics appoints Steve Healy as its new CEO Corex Logistics appoints Steve Healy as its new CEO Steve will guide the company's global expansion initiative Lonza appoints Juan Andres and Eric Drapé to its Board as independent members Lonza appoints Juan Andres and Eric Drapé to its Board as independent members The two bring a wealth of pharmaceutical knowledge, and have worked in a number of leadership positions at pharma giants such as Novo Nordisk, Moderna and Eli Lilly Steve Becker joins Broken String Biosciences as Chief Commercial Officer Steve Becker joins Broken String Biosciences as Chief Commercial Officer Steve's will help to push the company's INDUCE-seq commercialisation strategy forward Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer Chris' appointment will assist the company in making its commercial growth plans a reality Optibrium appoints James Halle as Chief Commercial Officer Optibrium appoints James Halle as Chief Commercial Officer James will assist the company in commercialising StarDrop, Cerella and Semeta, the company's proprietary drug development platforms Cherwell appoints Andy Charteris as new Director of Operations Cherwell appoints Andy Charteris as new Director of Operations Andy will assist Cherwell in its plans to acceleration its growth in the cleanroom space Vivet Therapeutics’ Dr Gloria Gonzalez-Aseguinolaza receives the Rosalind Franklin Society Special Award in Science Vivet Therapeutics’ Dr Gloria Gonzalez-Aseguinolaza receives the Rosalind Franklin Society Special Award in Science The award was appointed to Dr Gloria Gonzalez-Aseguinolaza for her work in advancing cell and gene therapies Mogrify appoints Dr Jonathan Appleby as Chief Scientific Officer Mogrify appoints Dr Jonathan Appleby as Chief Scientific Officer Dr Appleby has extensive experience in the development and commercialisation of both conventional and advanced therapeutics Cellular Origins appoints Geoffrey Hodge as Non-Executive Director Cellular Origins appoints Geoffrey Hodge as Non-Executive Director Geoff will contribute to the company's commercial growth efforts while also shaping the future direction of Cellular Origins